Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014
Reference Type:
study report
Title:
Unnamed
Year:
2015
Report date:
2015

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method

Test material

Constituent 1
Reference substance name:
heptadecyl (branched) methacrylate
EC Number:
810-817-1
Cas Number:
1473386-29-6
Molecular formula:
C21H40O2
IUPAC Name:
heptadecyl (branched) methacrylate
Constituent 2
Reference substance name:
C17 Methacrylate
IUPAC Name:
C17 Methacrylate
Details on test material:
- Name of test material (as cited in study report): C 17 Methacrylate
- Physical state: liquid/colorless, clear
- Analytical purity: > 99.2 %
- Lot/batch No.: S732030105

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Wiga GmbH, Germany
- Age at study initiation: Young adult animals (male animals approx. 8 weeks, female animals approx. 12 weeks)
- Weight at study initiation: Animals of comparable weight (± 20% of the mean weight, actual weights)
- Housing: Makrolon cage, type III, Single housing
- Diet (e.g. ad libitum): VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: at least 5 days before the beginning of the experimental phase

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 3°C
- Humidity (%): 30 - 70%
- Air changes (per hr): approx. 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: 40 cm²
- % coverage: 10
- Type of wrap if used: air-permeable dressing (4 layers of absorbent gauze (Ph. Eur. supplied by Lohmann GmbH & Co., KG) and stretch bandage (Fixomull® Stretch (adhesive fleece) supplied by Beiersdorf AG)

REMOVAL OF TEST SUBSTANCE
- Washing (if done): Afterwards removal of the semi-occlusive dressing, rinsing of the application site with warm water
- Time after start of exposure: 24 h
Duration of exposure:
24 h
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
5
Details on study design:
- Duration of observation period following administration: 14 days
- Other examinations performed: clinical signs, body weight, pathology

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Mortality:
No mortality occurred.
Clinical signs:
No systemic clinical signs were observed in male and female rats during clinical examination.
Three out of five male animals revealed very slight erythema (grade 1) from study day 1 until day 2 or 3, respectively. One out of five female animals revealed very slight erythema (grade 1) from study day 1 until day 2.
Body weight:
The mean body weight of the male animals increased within the normal range throughout the study period.
The body weight of four female animals stagnated during the first post-exposure week, but increased normally during the second week. The fifth female showed stagnation of body weight throughout the study period.
Gross pathology:
No macroscopic pathologic abnormalities were noted in the animals (5 males and 5 females) examined on the last day of observation.

Any other information on results incl. tables

Mortality

Dose (mg/kg bw):

5000

5000

Sex:

female

male

Administration:

1

1

No. of animals

5

5

Mortality (animals):

No mortality

No mortality

Under the conditions of this study the median lethal dose (LD50) of C 17 Methacrylate after dermal application was found to be greater than 5000 mg/kg bw in male and female rats.

Applicant's summary and conclusion